Research Article
Taxpas: Epidemiological and Survival Data in Breast Cancer Patients Treated with a Docetaxel-Based Chemotherapy Regimen in South Africa
Table 3
One-year survival according to stage and age.
| | | TNBC ≤ 50 years | N-TNBC ≤ 50 years | TNBC > 50 years | N-TNBC > 50 years |
| | Total | 99/120 (83%) | 571/637 (90%) | 88/112 (79%) | 611/763 (80%) | | Stage I | 15/17 (88%) | 43/46 (93%) | 8/9 (89%) | 33/36 (92%) | | Stage II | 45/46 (98%) | 210/218 (96%) | 37/39 (95%) | 211/225 (94%) | | Stage III | 20/22 (91%) | 159/171 (93%) | 13/16 (81%) | 130/139 (94%) | | Stage IV | 12/28 (43%) | 125/165 (76%) | 20/38 (53%) | 207/329 (63%) | | Stage unknown | 7/7 (100%) | 34/37 (92%) | 10/10 (100%) | 30/34 (88%) |
|
|
